- Type / Class
- Equity / Common Stock
- Shares outstanding
- 41,168,218
- Total 13F shares
- 15,811,115
- Share change
- +38,198
- Total reported value
- $35,574,319
- Put/Call ratio
- 0%
- Price per share
- $2.25
- Number of holders
- 39
- Value change
- +$288,225
- Number of buys
- 14
- Number of sells
- 21
Quarterly Holders Quick Answers
What is CUSIP 03837C106?
CUSIP 03837C106 identifies APYX - Apyx Medical Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03837C106:
Top shareholders of APYX - Apyx Medical Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Archon Capital Management LLC |
13F
|
Company |
8%
|
3,296,744
|
$4,516,539 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
7.9%
|
3,258,048
|
$4,463,526 | — | 31 Mar 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
6.1%
|
2,525,467
|
$3,459,890 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
1,475,772
|
$2,021,808 | — | 31 Mar 2025 | |
| Silverberg Bernstein Capital Management LLC |
13F
|
Company |
1.6%
|
646,569
|
$885,800 | — | 31 Mar 2025 | |
| HORIZON KINETICS ASSET MANAGEMENT LLC |
13F
|
Company |
1.5%
|
615,000
|
$842,550 | — | 31 Mar 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
1.4%
|
585,541
|
$802,000 | — | 31 Mar 2025 | |
| Taylor Frigon Capital Management LLC |
13F
|
Company |
1.2%
|
513,665
|
$703,721 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.2%
|
495,112
|
$678,303 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.87%
|
358,151
|
$490,798 | — | 31 Mar 2025 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.7%
|
287,976
|
$394,527 | — | 31 Mar 2025 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.5%
|
205,500
|
$281,535 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.49%
|
201,995
|
$276,733 | — | 31 Mar 2025 | |
| Kingsview Wealth Management, LLC |
13F
|
Company |
0.43%
|
175,095
|
$239,880 | — | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.36%
|
150,000
|
$205,500 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.29%
|
119,298
|
$163,439 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.27%
|
109,306
|
$149,749 | — | 31 Mar 2025 | |
| Caption Management, LLC |
13F
|
Company |
0.26%
|
107,947
|
$147,887 | — | 31 Mar 2025 | |
| Rathbones Group PLC |
13F
|
Company |
0.25%
|
101,334
|
$138,828 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.24%
|
99,300
|
$135,967 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
91,601
|
$125,493 | — | 31 Mar 2025 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.22%
|
90,750
|
$124,328 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.21%
|
84,609
|
$115,914 | — | 31 Mar 2025 | |
| GREENWOOD CAPITAL ASSOCIATES LLC |
13F
|
Company |
0.06%
|
23,671
|
$32,429 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
21,850
|
$29,934 | — | 31 Mar 2025 | |
| Joel Isaacson & Co., LLC |
13F
|
Company |
0.05%
|
20,500
|
$28,085 | — | 31 Mar 2025 | |
| Caprock Group, LLC |
13F
|
Company |
0.05%
|
20,000
|
$27,400 | — | 31 Mar 2025 | |
| SCHOLTZ & COMPANY, LLC |
13F
|
Company |
0.05%
|
20,000
|
$27,400 | — | 31 Mar 2025 | |
| Strategic Advisors LLC |
13F
|
Company |
0.05%
|
19,430
|
$26,619 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
14,057
|
$19,258 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
13,566
|
$18,585 | — | 31 Mar 2025 | |
| ProVise Management Group, LLC |
13F
|
Company |
0.03%
|
13,499
|
$18,494 | — | 31 Mar 2025 | |
| Ledgewood Wealth Advisors, LLC |
13F
|
Company |
0.02%
|
10,000
|
$13,700 | — | 31 Mar 2025 | |
| Matthew C. Hill |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
108,500
mixed-class rows
|
$9,605 | — | 15 May 2025 | |
| HighMark Wealth Management LLC |
13F
|
Company |
0.01%
|
5,000
|
$6,850 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
4,392
|
$6,017 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,308
|
$5,901 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
3,994
|
$5,000 | — | 31 Mar 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
2,575
|
$3,000 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
810
|
$1,110 | — | 31 Mar 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
400
|
$520 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
60
|
$82 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
15
|
$21 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
10
|
$14 | — | 31 Mar 2025 | |
| Charles D. Goodwin II |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
193,000
|
— | — | 15 May 2025 | |
| Stavros G. Vizirgianakis |
3/4/5
|
Director |
—
class O/S missing
|
128,000
|
— | — | 15 May 2025 | |
| Tara Semb |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
96,000
|
— | — | 11 Jan 2023 | |
| Wendy Lauren Levine |
3/4/5
|
Director |
—
class O/S missing
|
64,000
|
— | — | 15 May 2025 | |
| Minnie Baylor-Henry |
3/4/5
|
Director |
—
class O/S missing
|
59,000
|
— | — | 15 May 2025 | |
| Lawrence Waldman |
3/4/5
|
Director |
—
class O/S missing
|
30,000
|
— | — | 15 May 2025 |
Institutional Holders of Apyx Medical Corp - Common Stock (APYX) as of Q2 2025
As of 30 Jun 2025,
Apyx Medical Corp - Common Stock (APYX) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,811,115 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, Archon Capital Management LLC, ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, Silverberg Bernstein Capital Management LLC, COMMONWEALTH EQUITY SERVICES, LLC, HORIZON KINETICS ASSET MANAGEMENT LLC, BlackRock, Inc., Taylor Frigon Capital Management LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
43
Q2 2025 holders
39
Holder diff
-4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.